GIA
GHP Investment Advisors Portfolio holdings
AUM
$2.26B
1-Year Return
16.94%
This Quarter Return
+6.22%
1 Year Return
+16.94%
3 Year Return
+64.16%
5 Year Return
+118.81%
10 Year Return
+241.04%
AUM
$704M
AUM Growth
+$44.5M
(+6.7%)
Cap. Flow
+$9.62M
Cap. Flow
% of AUM
1.37%
Top 10 Holdings %
Top 10 Hldgs %
22.43%
Holding
313
New
15
Increased
165
Reduced
93
Closed
12
Top Buys
| 1 |
iShares Short Maturity Bond ETF
NEAR
|
$4.74M |
| 2 |
Apple
AAPL
|
$1.17M |
| 3 |
Invesco S&P International Developed Low Volatility ETF
IDLV
|
$846K |
| 4 |
Schwab International Equity ETF
SCHF
|
$755K |
| 5 |
RTX Corp
RTX
|
$703K |
Top Sells
Sector Composition
| 1 | Technology | 13.74% |
| 2 | Financials | 9.82% |
| 3 | Industrials | 9.56% |
| 4 | Healthcare | 6.16% |
| 5 | Consumer Staples | 5.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
AZZ Inc
AZZ
$3.51B
| $498K | 0.07% |
9,749
-5,205
| -35% | -$266K |
|
|
HES
227
DELISTED
Hess
HES
| $496K | 0.07% |
10,444
-557
| -5% | -$26.5K |
|
228
Coca-Cola
KO
$292B
| $481K | 0.07% |
10,484
+239
| +2% | +$11K |
|
229
Pfizer
PFE
$141B
| $480K | 0.07% |
13,962
-244
| -2% | -$8.39K |
|
230
Philip Morris
PM
$251B
| $476K | 0.07% |
4,506
+230
| +5% | +$24.3K |
|
231
Graham Corp
GHM
$524M
| $471K | 0.07% |
22,497
+2,467
| +12% | +$51.6K |
|
232
iShares Russell 2000 Growth ETF
IWO
$12.5B
| $471K | 0.07% |
2,523
-23
| -0.9% | -$4.29K |
|
233
TSMC
TSM
$1.26T
| $459K | 0.07% |
11,572
-840
| -7% | -$33.3K |
|
234
Idexx Laboratories
IDXX
$51.4B
| $444K | 0.06% |
2,838
| – | – |
|
235
Starbucks
SBUX
$97.1B
| $443K | 0.06% |
7,708
+33
| +0.4% | +$1.9K |
|
|
CDK
236
DELISTED
CDK Global, Inc.
CDK
| $440K | 0.06% |
6,169
+1
| +0% | +$71 |
|
237
CGI
GIB
$21.6B
| $438K | 0.06% |
8,055
+3,425
| +74% | +$186K |
|
|
IPHS
238
DELISTED
Innophos Holdings, Inc.
IPHS
| $424K | 0.06% |
9,081
+1,689
| +23% | +$78.9K |
|
|
EV
239
DELISTED
Eaton Vance Corp.
EV
| $420K | 0.06% |
7,444
-3,228
| -30% | -$182K |
|
240
Pediatrix Medical
MD
$1.49B
| $413K | 0.06% |
7,735
+940
| +14% | +$50.2K |
|
|
AMPE
241
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $407K | 0.06% |
333
| – | – |
|
242
Teva Pharmaceuticals
TEVA
$21.7B
| $404K | 0.06% |
21,303
+7,750
| +57% | +$147K |
|
|
UN
243
DELISTED
Unilever NV New York Registry Shares
UN
| $401K | 0.06% |
7,119
| – | – |
|
244
Check Point Software Technologies
CHKP
$20.7B
| $399K | 0.06% |
3,850
+220
| +6% | +$22.8K |
|
245
Gilead Sciences
GILD
$143B
| $386K | 0.05% |
5,394
+404
| +8% | +$28.9K |
|
246
Independent Bank
INDB
$3.55B
| $383K | 0.05% |
5,482
-276
| -5% | -$19.3K |
|
247
Biogen
BIIB
$20.6B
| $380K | 0.05% |
1,193
+113
| +10% | +$36K |
|
248
Owens & Minor
OMI
$434M
| $364K | 0.05% |
19,257
-22,542
| -54% | -$426K |
|
249
iShares Russell 2000 ETF
IWM
$67.8B
| $357K | 0.05% |
2,339
+41
| +2% | +$6.26K |
|
|
AABA
250
DELISTED
Altaba Inc. Common Stock
AABA
| $354K | 0.05% |
+5,071
| New | +$354K |
|